A carregar...
Assessing Outcomes in Prostate Cancer Clinical Trials: A 21st Century Tower of Babel
BACKGROUND: Due to the osseous distribution of prostate cancer metastases, progression is more readily identified than response in prostate cancer clinical trials. As a result, there is an increased focus on progression free survival (PFS) as a phase II endpoint. PFS, however, is vulnerable to inter...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2708077/ https://ncbi.nlm.nih.gov/pubmed/18661513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23719 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|